Shanghai CASB Biotechnology (China)
In research, Shanghai CASB Biotechnology (China) stands highest in Life Sciences (#4,571 of 7,800 worldwide), Medicine (#8,885 of 10,443 worldwide) and Health Sciences (#10,330 of 11,982 worldwide), 2022–2025.
- World rank, 2022–2025
- #9,207 of 28,054 · #19,294 all time
- Rank in China
- #1,742 of 3,058
- Research works
- 453 ▲ 98% vs 2013–17
- Citations
- 6.9k 15.2 per fractional work
- Top-10% rate
- 17.8% record average 16.5%
- Open access
- 39% world 28%
What is Shanghai CASB Biotechnology (China) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #4,571 of 7,800 | 19.2% | 93 | #8942 | |
| MedicineField | #8,885 of 10,443 | 14.2% | 63 | #16713 | |
| Health SciencesDomain | #10,330 of 11,982 | 14.3% | 74 | #19094 |
Each strip is that field’s whole ranked pool, with the notch where Shanghai CASB Biotechnology (China) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#8,942 #4,571
- Medicine#16,713 #8,885
- Health Sciences#19,094 #10,330
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 8.9×. Every wedge is a field page.
- Nursing 8.9×
- Immunology and Microbiology 7.3×
- Biochemistry, Genetics and Molecular Biology 4.4×
- Pharmacology, Toxicology and Pharmaceutics 3.7×
- Agricultural and Biological Sciences 2.5×
- Chemical Engineering 2.0×
- Chemistry 1.7×
- Veterinary 1.7×
- Medicine 1.6×
- Materials Science 1.1×
- Neuroscience 0.9×
- Energy 0.6×
- Dentistry 0.4×
- Engineering 0.3×
- Environmental Science 0.3×
- Computer Science 0.3×
- Health Professions 0.2×
- Physics and Astronomy 0.2×
- Economics, Econometrics and Finance 0.1×
- Arts and Humanities 0.1×
- Business, Management and Accounting 0.1×
- Decision Sciences 0.0×
- Social Sciences 0.0×
- Earth and Planetary Sciences 0.0×
- Mathematics 0.0×
- Psychology 0.0×
Which keywords describe research at Shanghai CASB Biotechnology (China)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Cancer Immunotherapy, Cancer, Tumor Regression, Antioxidant Activity, Lymphoma, Glycosylation and CAR T Cells.
- Cell Culture
- Proteins
- Fc Receptors
- Phenolic Compounds
- Probiotics
- Rheological Properties
- NK Cell Recognition
- Antigen Presentation
- Dietary Fiber
- Innate Immunity
- Antioxidants
- Immunity
- Metabolism
- Monoclonal Antibodies
- CAR T Cells
- Glycosylation
- Antioxidant Activity
- Oxidative Stress
- Inflammation
- Immunotherapy
- Cancer
- Cancer Immunotherapy
- Tumor Regression
- Nanoparticles
- Lymphoma
- Antioxidant
- Chimeric Antigen Receptor
- Health Benefits
- Therapeutic Antibodies
- Gut Microbiota
- Polyphenols
- Metabolic Health
- Fermentation
- Hydrocolloids
- Natural Killer Cells
- Gene Therapy
- Monoclonal Antibody
- Antibody Engineering
- Lipid Oxidation
- Tumor Targeting
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Cancer13▲ 4.6×36 topics
- Immunotherapy12▲ 8.4×11 topics
- Cancer Immunotherapy11▲ 34×3 topics
- Inflammation10▲ 2.3×43 topics
- Tumor Regression10▲ 42×2 topics
- Oxidative Stress9▲ 2.7×28 topics
- Nanoparticles9▲ 3.5×20 topics
- Antioxidant Activity9▲ 6.7×16 topics
- Lymphoma8▲ 24×3 topics
- Glycosylation8▲ 33×3 topics
- Antioxidant7▲ 5.1×26 topics
- CAR T Cells7▲ 47×1 topic
- Chimeric Antigen Receptor7▲ 47×1 topic
- Monoclonal Antibodies7▲ 38×3 topics
- Health Benefits7▲ 10×10 topics
- Metabolism6▲ 5.8×18 topics
- Therapeutic Antibodies6▲ 43×2 topics
- Immunity6▲ 7.1×7 topics
- Gut Microbiota6▲ 7.9×7 topics
- Antioxidants6▲ 6.0×8 topics
- Polyphenols5▲ 14×5 topics
- Innate Immunity5▲ 7.8×8 topics
- Metabolic Health5▲ 13×2 topics
- Dietary Fiber5▲ 21×3 topics
- Fermentation5▲ 16×6 topics
- Antigen Presentation4▲ 25×2 topics
- Hydrocolloids4▲ 28×2 topics
- NK Cell Recognition4▲ 33×1 topic
- Natural Killer Cells4▲ 33×1 topic
- Rheological Properties4▲ 12×2 topics
- Gene Therapy4▲ 11×4 topics
- Probiotics4▲ 9.0×4 topics
- Monoclonal Antibody4▲ 40×2 topics
- Phenolic Compounds4▲ 11×7 topics
- Antibody Engineering4▲ 37×1 topic
- Fc Receptors4▲ 37×1 topic
- Lipid Oxidation4▲ 20×2 topics
- Proteins4▲ 22×2 topics
- Tumor Targeting4▲ 11×3 topics
- Cell Culture4▲ 17×3 topics
Which research topics does Shanghai CASB Biotechnology (China) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, Monoclonal and Polyclonal Antibodies Research and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 7 works
- 2 Immune Cell Function and Interaction Immunology 4 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 4 works
- 4 Immunotherapy and Immune Responses Immunology 3 works
- 5 Proteins in Food Systems Food Science 3 works
- 6 Food composition and properties Nutrition and Dietetics 3 works
- 7 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 3 works
- 8 Skin Protection and Aging Dermatology 3 works
- 9 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 10 Cancer Research and Treatments Biotechnology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Shanghai CASB Biotechnology (China)'s research output changed?
Output in 2018–2022 was 98% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shanghai
- Shanghai Jiao Tong University
- Tongji University
- Fudan University
- Shanghai University
- East China Normal University
- East China University of Science and Technology
- Donghua University
- University of Shanghai for Science and Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.